Glenview Trust Co acquired a new position in Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, HoldingsChannel reports. The firm acquired 10,662 shares of the conglomerate’s stock, valued at approximately $2,031,000.
Other large investors have also recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of Danaher during the second quarter valued at approximately $10,492,520,000. Norges Bank purchased a new position in Danaher during the 4th quarter valued at $2,177,106,000. Jupiter Topco LLC bought a new position in Danaher in the 2nd quarter worth $1,456,317,000. Generation Investment Management LLP purchased a new stake in shares of Danaher in the 2nd quarter worth about $1,287,949,000. Finally, Bank of America Corp DE purchased a new stake in shares of Danaher in the 2nd quarter worth about $993,846,000. 79.05% of the stock is currently owned by institutional investors.
Danaher Price Performance
Shares of DHR opened at $216.41 on Friday. The stock has a market cap of $152.13 billion, a PE ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm’s 50-day simple moving average is $199.46 and its two-hundred day simple moving average is $192.52.
Analysts Set New Price Targets
Several equities analysts recently issued reports on DHR shares. HSBC reduced their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Royal Bank Of Canada upped their target price on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Evercore restated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Finally, Wells Fargo & Company dropped their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $228.91.
View Our Latest Research Report on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
